Boston Scientific (BSX) Treasury Shares (2009 - 2026)

Boston Scientific has disclosed Treasury Shares across 16 years of filings, most recently posting $2.3 billion for Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.3 billion, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 billion (changed 0.0% YoY), and the FY2025 annual result was $2.3 billion, changed 0.0% from the prior year.
• Treasury Shares came in at $2.3 billion for Q1 2026 at Boston Scientific, roughly flat from $2.3 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $263.3 million in Q1 2022 to a low of $9.3 million in Q4 2023.
• The 5-year median for Treasury Shares is $263.3 million (2022), against an average of $224.2 million.
• Peak annual rise in Treasury Shares reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Boston Scientific's Treasury Shares stood at $2.3 billion in 2022, then changed by 0.0% to $2.3 billion in 2023, then changed by 0.0% to $2.3 billion in 2024, then changed by 0.0% to $2.3 billion in 2025, then changed by 0.0% to $2.3 billion in 2026.
• The last three Treasury Shares figures came in at $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.3 billion (Q3 2025), per Business Quant data.